RBM22 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.603620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.461000E-01
Normal-vs-Stage2
1.475620E-01
Normal-vs-Stage3
7.546200E-02
Normal-vs-Stage4
5.653200E-01
Stage1-vs-Stage2
1.086230E-01
Stage1-vs-Stage3
1.418040E-01
Stage1-vs-Stage4
6.399200E-01
Stage2-vs-Stage3
8.282500E-02
Stage2-vs-Stage4
3.769000E-01
Stage3-vs-Stage4
1.025030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.567380E-01
Normal-vs-AfricanAmerican
1.425620E-01
Normal-vs-Asian
2.351000E-01
Caucasian-vs-AfricanAmerican
6.447600E-01
Caucasian-vs-Asian
7.384200E-01
AfricanAmerican-vs-Asian
8.799800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.241800E-01
Normal-vs-Female
9.712100E-02
Male-vs-Female
3.341800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.264600E-01
Normal-vs-Age(41-60Yrs)
3.884600E-01
Normal-vs-Age(61-80Yrs)
1.094770E-01
Normal-vs-Age(81-100Yrs)
9.304900E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.974000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.961000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.167400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.68860000000693E-05
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.199700E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.872800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.183700E-02
Normal-vs-Daily Drinker
2.674600E-01
Normal-vs-Weekly Drinker
1.006580E-01
Normal-vs-Occasional Drinker
2.129000E-01
Normal-vs-Social Drinker
1.927390E-01
Non Drinker-vs-Daily Drinker
2.563600E-01
Non Drinker-vs-Weekly Drinker
9.706600E-01
Non Drinker-vs-Occasional Drinker
1.098830E-01
Non Drinker-vs-Social Drinker
2.076000E-01
Daily Drinker-vs-Weekly Drinker
3.400400E-01
Daily Drinker-vs-Occasional Drinker
7.082200E-01
Daily Drinker-vs-Social Drinker
8.885400E-01
Weekly Drinker-vs-Occasional Drinker
1.512830E-01
Weekly Drinker-vs-Social Drinker
2.522800E-01
Occasional Drinker-vs-Social Drinker
8.065800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.236640E-01
Normal-vs-Grade 2
4.011800E-01
Normal-vs-Grade 3
7.117200E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.997000E-01
Grade 1-vs-Grade 3
2.587200E-01
Grade 1-vs-Grade 4
1.236640E-01
Grade 2-vs-Grade 3
7.706000E-01
Grade 2-vs-Grade 4
4.011800E-01
Grade 3-vs-Grade 4
7.117200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.096400E-02
Normal-vs-NonDiabetic
1.844790E-01
Diabetic-vs-NonDiabetic
2.397400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.773200E-01
Normal-vs-NoPancreatitis
1.573640E-01
Pancreatitis-vs-NoPancreatitis
7.169400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.156000E-01
Normal-vs-N1
1.522630E-01
N0-vs-N1
3.009000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.589600E-01
Normal-vs-TP53-NonMutant
3.805200E-01
TP53-Mutant-vs-TP53-NonMutant
5.487400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
